Literature DB >> 17384899

Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients.

Gloria E Westney1, Sadia Habib, Alexander Quarshie.   

Abstract

Sarcoidosis disease expression differs along racial/ethnic lines and black race has been cited as a poor prognostic factor. Besides genetic, healthcare, and socioeconomic factors, comorbid illnesses may influence sarcoidosis disease expression. We set out to investigate the association between comorbid illnesses and chest radiographic severity in a population of African-American sarcoidosis patients. The study was designed as a retrospective database analysis. The hospital and outpatient databases of the Grady Health System were searched to capture adult patients between November 1999 and December 2003 with the ICD-9 codes of 135 or 519.8, along with all associated secondary and tertiary diagnostic codes. Patient electronic pathology and radiographic reports were reviewed for tissue biopsies showing noncaseating granulomas and for chest radiographic Scadding stage. A total of 165 African-American patients were identified (64% female, 43 +/- 10 years old). Ninety percent (149/165) had comorbid illnesses. The most frequent chronic comorbid illnesses were hypertension (39%), diabetes mellitus (19%), anemia (19%), asthma (15%), gastroesophageal reflux disease (15%), depression (13%), and heart failure (10%). Females had increased frequency and clustering of chronic illnesses. Chest radiographic stages were more severe in patients with anemia, depression, and those less than 40 years old. Males, within each chronic illnesses category, had more severe CXR stages compared to females; however, significance was not achieved. We concluded that most adult patients with sarcoidosis have comorbid illnesses and these, in addition to gender differences, may influence sarcoidosis disease expression. Screening for comorbid illnesses should be an important aspect of sarcoidosis patient management.

Entities:  

Mesh:

Year:  2007        PMID: 17384899     DOI: 10.1007/s00408-007-9008-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  23 in total

1.  Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks.

Authors:  Sharon K Davis; Yong Liu; Gary H Gibbons
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

2.  Overcoming disparities in U.S. health care.

Authors:  William H Frist
Journal:  Health Aff (Millwood)       Date:  2005 Mar-Apr       Impact factor: 6.301

Review 3.  Measurement issues in health disparities research.

Authors:  Mildred Ramírez; Marvella E Ford; Anita L Stewart; Jeanne A Teresi
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

Review 4.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

5.  Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions.

Authors:  H L Israel; P Karlin; H Menduke; O G DeLisser
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

6.  Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy.

Authors:  Jerome M Reich
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

7.  The spectrum of biopsy sites for the diagnosis of sarcoidosis.

Authors:  Alvin S Teirstein; Marc A Judson; Robert P Baughman; Milton D Rossman; Henry Yeager; David R Moller
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2005-06       Impact factor: 0.670

8.  Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy.

Authors:  J E Gottlieb; H L Israel; R M Steiner; J Triolo; H Patrick
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

9.  Sarcoidosis: benefits of a multidisciplinary approach.

Authors:  M Drent
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

10.  The anemia of sarcoidosis.

Authors:  E E Lower; J T Smith; O J Martelo; R P Baughman
Journal:  Sarcoidosis       Date:  1988-03
View more
  6 in total

1.  Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis.

Authors:  Willane Krell; Julie M Bourbonnais; Rajat Kapoor; Lobelia Samavati
Journal:  Lung       Date:  2012-07-08       Impact factor: 2.584

2.  Sarcoidosis in black women in the United States: data from the Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; David M Serlin; Lynn Rosenberg
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

3.  Sarcoidosis and increased risk of comorbidities and mortality in sweden.

Authors:  Johanna Larsson; Pål Graff; Ing-Liss Bryngelsson; Per Vihlborg
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

4.  Racial differences in sarcoidosis granuloma density.

Authors:  Robert R Burke; Chad H Stone; Suzanne Havstad; Benjamin A Rybicki
Journal:  Lung       Date:  2008-08-21       Impact factor: 2.584

Review 5.  Comprehensive Care for Patients with Sarcoidosis.

Authors:  Catharina C Moor; Vivienne Kahlmann; Daniel A Culver; Marlies S Wijsenbeek
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

Review 6.  Catch the rainbow: Prognostic factor of sarcoidosis.

Authors:  Senol Kobak
Journal:  Lung India       Date:  2020 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.